325 related articles for article (PubMed ID: 27105922)
1. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder.
Lee MY; Kim EY; Kim SH; Cho KC; Ha K; Kim KP; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():60-8. PubMed ID: 27105922
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of major depressive disorder by combining multimodal information from heart rate dynamics and serum proteomics using machine-learning algorithm.
Kim EY; Lee MY; Kim SH; Ha K; Kim KP; Ahn YM
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():65-71. PubMed ID: 28223106
[TBL] [Abstract][Full Text] [Related]
3. Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients.
Stelzhammer V; Haenisch F; Chan MK; Cooper JD; Steiner J; Steeb H; Martins-de-Souza D; Rahmoune H; Guest PC; Bahn S
Int J Neuropsychopharmacol; 2014 Oct; 17(10):1599-608. PubMed ID: 24901538
[TBL] [Abstract][Full Text] [Related]
4. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
[TBL] [Abstract][Full Text] [Related]
5. Serum lipidomic analysis for the discovery of biomarkers for major depressive disorder in drug-free patients.
Kim EY; Lee JW; Lee MY; Kim SH; Mok HJ; Ha K; Ahn YM; Kim KP
Psychiatry Res; 2018 Jul; 265():174-182. PubMed ID: 29719272
[TBL] [Abstract][Full Text] [Related]
6. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
[TBL] [Abstract][Full Text] [Related]
8. Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells.
Zheng P; Fang Z; Xu XJ; Liu ML; Du X; Zhang X; Wang H; Zhou J; Xie P
J Affect Disord; 2016 May; 195():75-81. PubMed ID: 26874244
[TBL] [Abstract][Full Text] [Related]
9. Serum proteomic profiling of major depressive disorder.
Bot M; Chan MK; Jansen R; Lamers F; Vogelzangs N; Steiner J; Leweke FM; Rothermundt M; Cooper J; Bahn S; Penninx BW
Transl Psychiatry; 2015 Jul; 5(7):e599. PubMed ID: 26171980
[TBL] [Abstract][Full Text] [Related]
10. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
[TBL] [Abstract][Full Text] [Related]
11. Plasma metabolome analysis of patients with major depressive disorder.
Kawamura N; Shinoda K; Sato H; Sasaki K; Suzuki M; Yamaki K; Fujimori T; Yamamoto H; Osei-Hyiaman D; Ohashi Y
Psychiatry Clin Neurosci; 2018 May; 72(5):349-361. PubMed ID: 29356314
[TBL] [Abstract][Full Text] [Related]
12. Plasma lipidomics reveals potential lipid markers of major depressive disorder.
Liu X; Li J; Zheng P; Zhao X; Zhou C; Hu C; Hou X; Wang H; Xie P; Xu G
Anal Bioanal Chem; 2016 Sep; 408(23):6497-507. PubMed ID: 27457104
[TBL] [Abstract][Full Text] [Related]
13. Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers.
Dahl J; Andreassen OA; Verkerk R; Malt UF; Sandvik L; Brundin L; Ormstad H
Psychoneuroendocrinology; 2015 Jun; 56():12-22. PubMed ID: 25770856
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of serum from patients with major depressive disorder to compare their depressive and remission statuses.
Lee J; Joo EJ; Lim HJ; Park JM; Lee KY; Park A; Seok A; Lee H; Kang HG
Psychiatry Investig; 2015 Apr; 12(2):249-59. PubMed ID: 25866527
[TBL] [Abstract][Full Text] [Related]
15. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
16. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
[TBL] [Abstract][Full Text] [Related]
17. Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation.
Xu HB; Zhang RF; Luo D; Zhou Y; Wang Y; Fang L; Li WJ; Mu J; Zhang L; Zhang Y; Xie P
Int J Neuropsychopharmacol; 2012 Nov; 15(10):1413-25. PubMed ID: 22717272
[TBL] [Abstract][Full Text] [Related]
18. Identifying Plasma Biomarkers with high specificity for major depressive disorder: A multi-level proteomics study.
Shi Y; Song R; Wang L; Qi Y; Zhang H; Zhu J; Zhang X; Tang X; Zhan Q; Zhao Y; Swaab DF; Bao AM; Zhang Z
J Affect Disord; 2020 Dec; 277():620-630. PubMed ID: 32905914
[TBL] [Abstract][Full Text] [Related]
19. Plasma amino acid profile in major depressive disorder: Analyses in two independent case-control sample sets.
Ogawa S; Koga N; Hattori K; Matsuo J; Ota M; Hori H; Sasayama D; Teraishi T; Ishida I; Yoshida F; Yoshida S; Noda T; Higuchi T; Kunugi H
J Psychiatr Res; 2018 Jan; 96():23-32. PubMed ID: 28950111
[TBL] [Abstract][Full Text] [Related]
20. Identification of altered protein expression in major depressive disorder and bipolar disorder patients using liquid chromatography-tandem mass spectrometry.
Kim H; Rhee SJ; Lee H; Han D; Lee TY; Kim M; Kim EY; Kwon JS; Shin H; Kim H; Ahn YM; Ha K
Psychiatry Res; 2021 May; 299():113850. PubMed ID: 33711561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
